FcR Therapeutics
PrivateLast Round
Seed
Feb 4, 2025
Company Overview
FcR Therapeutics is a biotechnology company that develops recombinant nanobody-based therapeutics to modulate Fc receptor activity for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FcR Therapeutics Comparables
Compare FcR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kaigene Inc. | 79% | |
| Nuvig Therapeutics | 78% | |
| Cerberus Therapeutics | 77% |
FcR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 4, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 168% MoM, reaching 260.
FcR Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FcR Therapeutics's valuation, stock price, and market status.
Is FcR Therapeutics a public or private company?
FcR Therapeutics is a private company.
What is the current stock price of FcR Therapeutics?
FcR Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is FcR Therapeutics worth (valuation)?
Valuation information for FcR Therapeutics is not publicly available.
Can I buy FcR Therapeutics stock?
FcR Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FcR Therapeutics's last funding round?
FcR Therapeutics's most recent funding round was Seed on February 4, 2025.
Who are the main investors in FcR Therapeutics?
Investor information for FcR Therapeutics is not publicly disclosed.
Will FcR Therapeutics IPO soon?
No public IPO plans have been announced for FcR Therapeutics.
How can I track FcR Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FcR Therapeutics's secondary market activity and sign up for updates.